TRANSPARENCY

As a United Nations agency, UNOPS operates in a transparent and responsible manner, under the principles of access to information, accountability, and advocacy for spaces for open dialogue with different counterparts.

INDEX

Reports

Consult the reports

Consult the reports

Committed to transparency and accountability, UNOPS in Mexico presents:

Second Report of the on the purchase of medicines and medical supplies and devices for the second half of 2022. (In spanish)

Consult the second report

First Report of the purchase of medicines and medical supplies - Consult report(In spanish)

Suppliers and contracted codes

Codes retained through international public tenders (IPB) 2022

In those lists, ITB 2022processes are found, where the retained codes, description, offering supplier, offer currency, price, tendered quantity and retained quantity are shown, for the procurement of medicines, medical supplies, and devices.

51944788302 6835f5c7d3 b

UNOPS contracted suppliers

Within the framework of the Agreement signed by UNOPS and between INSABI, for the management of the consolidated procurement of medicines and medical supplies and devices for 2021-2024, here you may find the retained codes

Access to the list of contracted suppliers for the procurement of medicines and medical supplies and devices for 2021

Claves y oferentes

Codes retained through international public tenders (IPB) 2021

In those lists, ITB processes 2021 are found, where the retained codes, description, offering supplier, offer currency, price, tendered quantity and retained quantity are shown, for the procurement of medicines, medical supplies, and devices.

Hospital 20 nov 21 jun2022 3

Retained codes for medicines through Long Term Agreements and Amendments

The following lists belong to the keys contracted through LTAs and Amendments to contracts established in 2021 and extended to 2022

HOSPITAL 20 NOVIEMBRE23 05 22 09282

UNOPS Accountability

Who audits UNOPS and ensures transparency?

As a United Nations agency, UNOPS operates in a transparent and responsible manner, under the principles of access to information, accountability, and advocacy for spaces for open dialogue.

UNOPS conducted the international public bidding process with multiple control and quality filters, based on the rules of integrity, transparency, and open competition, which prohibit any type of preferential treatment to any offeror. UNOPS governing body is its Executive Board, made up of 36 UN member states who serve on a rotating basis and are elected for a period of three years. The Board sets its accountability framework, oversight mechanisms and policies.

In addition to the role of the Executive Board, UNOPS is overseen by:

Access to information

878 million pieces of medicines, medical supplies and devices were purchased in 7 countries

Code purchased for 2021 and the first half of 2022

1,050

Codes purchased

707

Medicines

343

Medical supplies and devices

Codes purchased for supply in the second half of 2022

569

Codes

313

Medicines

256

Medical supplies and devices

INSABI-UNOPS joint report (2021)

INSABI-UNOPS joint report (2021)

This report describes the steps that were derived from the collaboration agreement by the Government of Mexico through INSABI and between UNOPS

Consult the join report (In spanish)

Due dilligence

Lopesz mateos 8 03 22 28

UNOPS due diligence process

The procurement by UNOPS, in conjunction with health institutions, was carried out by following a due diligence process aligned with the best international practices, which seek that the Mexican population gets the highest health benefits. All retained companies have been subject to a strict verification process that guarantees transparency and competition. Likewise, it has been possible to reduce the market concentration, which offers products with better prices and quality.

At the end of the project, 97 providers accounted for 80% of drug spending, while in 2018 this percentage lied in the hands of 18 suppliers. This means that great progress was made in terms of supplier diversification.

Regular meetings with different counterparts